Versor Investments LP acquired a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 1,628 shares of the biotechnology company’s stock, valued at approximately $651,000.
Several other large investors have also made changes to their positions in AXON. 1832 Asset Management L.P. acquired a new stake in Axon Enterprise during the 1st quarter worth about $81,630,000. International Assets Investment Management LLC purchased a new position in Axon Enterprise during the third quarter valued at approximately $871,860,000. Vanguard Group Inc. lifted its holdings in Axon Enterprise by 2.7% in the first quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock valued at $2,547,878,000 after acquiring an additional 212,401 shares during the period. Swedbank AB purchased a new stake in Axon Enterprise in the 1st quarter worth approximately $39,923,000. Finally, Vaughan Nelson Investment Management L.P. grew its stake in shares of Axon Enterprise by 53.2% during the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 157,094 shares of the biotechnology company’s stock worth $46,223,000 after purchasing an additional 54,526 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on AXON shares. Barclays increased their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Robert W. Baird raised their target price on Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. The Goldman Sachs Group upped their price target on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Jefferies Financial Group started coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 price objective on the stock. Finally, Needham & Company LLC increased their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $427.83.
Insider Activity at Axon Enterprise
In other Axon Enterprise news, Director Jeri Williams sold 110 shares of the firm’s stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $400.00, for a total value of $44,000.00. Following the transaction, the director now directly owns 1,934 shares of the company’s stock, valued at $773,600. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $373.03, for a total value of $167,863.50. Following the transaction, the director now directly owns 7,379 shares in the company, valued at $2,752,588.37. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Jeri Williams sold 110 shares of the firm’s stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $400.00, for a total transaction of $44,000.00. Following the sale, the director now owns 1,934 shares of the company’s stock, valued at $773,600. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 389,172 shares of company stock valued at $148,393,842. Corporate insiders own 6.10% of the company’s stock.
Axon Enterprise Price Performance
Axon Enterprise stock opened at $601.29 on Thursday. The company has a fifty day simple moving average of $428.90 and a 200-day simple moving average of $353.54. The firm has a market capitalization of $45.85 billion, a price-to-earnings ratio of 155.37, a PEG ratio of 14.95 and a beta of 0.94. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 52-week low of $220.51 and a 52-week high of $624.84.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Recommended Stories
- Five stocks we like better than Axon Enterprise
- Breakout Stocks: What They Are and How to Identify Them
- Rocket Lab is the Right Stock for the Right Time
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.